MarketPeel
Insider Trading Intelligence
AM

Arie Mayer

ORMP
DIRECTOR · ORAMED PHARMACEUTICALS INC. · CIK 0001796583
FILING MIX · LIFETIME93%/7%
BUYS
14
SELLS
1
TOTAL VALUE
$96.3K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
163,109
AVG SELL PX
$25.60
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Arie Mayer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+0.00%+5.30%+0.62%+4.68%-0.26%
14d3+66.67%+6.85%+1.23%+5.62%+3.74%
30d3+100.00%+7.42%-1.22%+8.64%+26.05%
60d3+100.00%+41.65%+4.15%+37.50%+77.77%
90d3+100.00%+19.93%+5.18%+14.76%+51.79%
180d3+100.00%-14.14%+0.08%-14.22%+13.32%
1y3+100.00%-6.34%+13.96%-20.30%-1.62%
2y3+33.33%-31.21%+23.60%-54.81%-41.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORMP · 163,109 shares · as of Dec 31, 2025
042,00284,005126,007168,00920212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 14 buys / 1 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
4,900168,009Dec 31, 2025Jan 5, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,000163,109Dec 31, 2025Jan 5, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
6,975133,109Jun 5, 2025Jun 9, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,000126,134Jun 5, 2025Jun 9, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
9,32596,134Jan 4, 2024Jan 8, 2024View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,00086,809Jan 4, 2024Jan 8, 2024View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
30,00056,809Apr 17, 2023Apr 20, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
3,800$2.21$8.4K26,809Apr 4, 2023Apr 4, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
5,009$2.22$11.1K23,009Apr 3, 2023Apr 4, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
12,00018,000Jul 28, 2022Aug 1, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
6,0006,000Jan 3, 2022May 10, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
10,00010,000Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
6,0009,000Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
3,000$25.60$76.8K0Nov 1, 2021May 10, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
20,00020,000Jan 8, 2020Jan 14, 2020View →
Other insiders · ORMP
Loading peer insiders…
About this filer
CIK 0001796583
ROLE
Director
PRIMARY
ORMP
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001796583DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback